Surface Oncology: Soars after report says company exploring potential sale
12/10/2020 18:59
** Shares of drug developer SURF.O jump 17% to $8.3, hit
their highest in almost 2 years
** Company is exploring a potential sale after
GlaxoSmithKline Plc's GSK.L takeover bid, Street Insider
reports, citing a source (https://bit.ly/30YMMde)
** Report says SURF has hired an investment bank to explore
its sale
** Stock has risen 341% so far this year
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com;))
Recent news on Surface Oncology
See all newsBrief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers
Surface Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surface Oncology, Inc. Q2 Net Income USD -28.2 Mln
Surface Oncology Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: ADAR1 Partners Reports 5.24% Passive Stake In Surface Oncology Inc As Of July 10 - SEC Filing